ANI Pharmaceuticals | ANIP - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
AbbVie USD -5.94B 721M 2026-06
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Aurora Cannabis CAD 511.83M 24.53M 2026-03
Canopy Growth CAD 697.59M 60.58M 2026-03
Eli Lilly USD 33.88B 2.68B 2026-06
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Heron Therapeutics USD 6.91M 2.23M 2026-06
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Knight Therapeutics CAD 767.27M 480K 2025-12
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Novartis USD 38.93B 7.2B 2026-03
Omeros USD -228.68M 15.13M 2025-06
Perrigo USD 2.52B 17M 2026-06
Sun Pharmaceuticals INR 835.7B 57.5B 2026-03
Teva Pharmaceutical Industries USD 7.75B 475M 2026-06